Comparison of efficacy and safety of combination of abiraterone and prednisone in treatment of non-metastatic castration-resistant prostate cancer

Huang Renzhao; Zheng Ruinian; Liang Zhenfeng; Ye Zhaohua; Li Zhixiong

doi:10.3969/j.issn.0253-9802.2021.05.013

Huang Renzhao, Zheng Ruinian, Liang Zhenfeng, Ye Zhaohua, Li Zhixiong

JOURNAL OF NEW MEDICINE ›› 2021, Vol. 52 ›› Issue (5) : 365-370.

PDF(1056 KB)

JOURNAL OF NEW MEDICINE ›› 2021, Vol. 52 ›› Issue (5) : 365-370. DOI: 10.3969/j.issn.0253-9802.2021.05.013

Original Research

Comparison of efficacy and safety of combination of abiraterone and prednisone in treatment of non-metastatic castration-resistant prostate cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 52(5): 365-370 https://doi.org/10.3969/j.issn.0253-9802.2021.05.013

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(1056 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2020-12-23	2021-05-15
Issue Date
2021-06-09

Please choose a citation manager

Content to export